Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China flag China · Delayed Price · Currency is CNY
12.31
-0.12 (-0.97%)
Sep 10, 2026, 12:44 PM CST

SHE:002275 Revenue

Guilin Sanjin Pharmaceutical had revenue of 443.48M CNY in the quarter ending June 30, 2026, a decrease of -16.60%. This brings the company's revenue in the last twelve months to 2.02B, down -5.08% year-over-year. In the year 2025, Guilin Sanjin Pharmaceutical had annual revenue of 2.05B, down -6.76%.

Revenue (ttm)
2.02B
Revenue Growth
-5.08%
P/S Ratio
3.62
Revenue / Employee
788.73K
Employees
2,556
Market Cap
7.30B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.05B-148.26M-6.76%
Dec 31, 20242.19B22.39M1.03%
Dec 31, 20232.17B211.87M10.81%
Jan 1, 20231.96B218.51M12.55%
Jan 1, 20221.74B174.74M11.15%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.